Status:
COMPLETED
CIRSE Registry for SIR-Spheres Therapy
Lead Sponsor:
Cardiovascular and Interventional Radiological Society of Europe
Conditions:
Liver Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The administration of SIR-Spheres microspheres (yttrium-90 resin microspheres) is a form of selective internal radiation therapy (SIRT) for the treatment of patients with primary and secondary liver t...
Detailed Description
Selective internal radiation therapy (SIRT), also called radioembolisation (RE), with SIR-Spheres microspheres is an endovascular procedure, included within the interventional oncologic technologies t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Treatment of liver tumour with SIR-spheres microspheres
- Primary or secondary liver tumours
- Signed informed consent form
- 18 years or older
- Exclusion criteria
- Under 18 years
Exclusion
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
1051 Patients enrolled
Trial Details
Trial ID
NCT02305459
Start Date
November 1 2014
End Date
January 1 2020
Last Update
January 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular and Interventional Radiological Society of Europe
Vienna, Austria, 1010